ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung - 
66135001 Janssen-Cilag AG
Stelara 130 mg, Konzentrat zur Herstellung einer Infusionslösung02.06.2017
  02.06.2017
Ustekinumab (L04AC05) 
WHO-DDD01.06.2022
07.15. 
07.15. 
B  
Yes 
IP 
3233.32Yes
    
10 %3560.15
7680661350015Biotechnologika
7136323 
Composition
ustekinumabum 130 mg, histidinum, histidini hydrochloridum monohydricum, saccharum, polysorbatum 80, dinatrii edetas, antiox.: methioninum, aqua ad iniectabilia q.s. ad solutionem pro 26 ml.
Packungsbestandteile
Concentrate for infusion
 
 
Active AgentDose
Ustekinumabum130mg / 26ml
 
Inactive agents additional_information
Dinatrii Edetas  
Histidin Hydrochloride Monohydrate  
Histidine  
Methionine antiox.
Polysorbatum 80  
Saccharum  
Source
Data was imported : 05.04.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2020 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home